Please assess the completion status of the following clinical trial:

Trial Title: Global Lomitapide Pregnancy Exposure Registry

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Pregnant females exposed to lomitapide at any time within 30 days prior to first day of the LMP or during pregnancy.~Exclusion Criteria:~* Patients who are unable or unwilling to provide written informed consent or assent are not eligible to participate in the PER.

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).